Virtu Financial LLC Benitec Biopharma Inc. Transaction History

Virtu Financial LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$0.19 - $0.36 $13,042 - $24,712	-68,645 Reduced 56.49%	52,869 $13,000
Q1 2023 May 01, 2023	BUY	$0.18 - $0.36 $7,316 - $14,632	40,647 Added 50.26%	121,514 $26,000
Q4 2022 Feb 15, 2023	BUY	$0.13 - $5.95 $10,512 - $481,158	80,867 New	80,867 $14,000
Q2 2022 Aug 09, 2022	BUY	$0.74 - $2.29 $35,070 - $108,529	47,393 New	47,393 $55,000
Q1 2022 May 17, 2022	SELL	$1.96 - $2.96 $20,493 - $30,949	-10,456 Closed	0 $0
Q4 2021 Feb 17, 2022	SELL	$2.62 - $3.77 $32,666 - $47,004	-12,468 Reduced 54.39%	10,456 $27,000
Q3 2021 Nov 12, 2021	BUY	$3.49 - $4.26 $80,004 - $97,656	22,924 New	22,924 $82,000
Q2 2021 Sep 17, 2021	SELL	$3.94 - $5.81 $88,728 - $130,841	-22,520 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$2.59 - $9.26 $8,821 - $31,539	3,406 Added 17.82%	22,520 $116,000
Q4 2020 Feb 24, 2021	BUY	$2.61 - $4.79 $49,887 - $91,556	19,114 New	19,114 $57,000

797K

Ticker BNTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,809,500
Market Cap $299M
Description
Benitec Biopharma Inc., a development-stage biotechnology company, focuses on the development of novel genetic medicines. The company develops DNA-directed RNA interference based therapeutics for chronic and life-threatening human conditions. It is developing BB-301, an adeno-associated virus based gene therapy agent for treating oculopharyngeal...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.